Legal Adult-Use Cannabis Sales Started in the State of Connecticut

Nine medical cannabis dispensaries have been licensed to sell cannabis to adults 21 years of age or older and will be open to new customers in Connecticut.

As part of the legalization of recreational cannabis, nearly 44,000 convictions for possession of small amounts of cannabis have been completely or partially removed thanks to Connecticut’s new “clean slate” law.

Now, as adult-use cannabis sales begin in Connecticut, Department of Consumer Protection Commissioner Michelle Seagull has called on businesses and consumers to be responsible.

“This is intended for adults,” Seagull said. “There’s always a risk or concern that people won’t take responsibility as seriously as they should, and the product will get into the wrong hands.”

New Haven Police Chief Karl Jacobson said Monday that supplying marijuana to minors is illegal and will continue to be treated as a crime. He also said that cannabis products must remain unopened when transported in a car.

“One of the illegal things is, of course, driving under the influence,” he said. “But both passengers and drivers are not allowed to use marijuana while driving.”

He also said that cannabis cannot be smoked in places where smoking is prohibited, such as city parks, schools, and inside buildings.

read more about the legal cannabis market in Connecticut and find the most important cannabis news from around the world with the Hemp.im mobile app.

What Connecticut residents can buy

Initial sales of cannabis to adults will be limited to:

7 grams of cannabis
4 ml of vape pen cartridges
7 grams in pre-rolls
Food products that use no more than 7g of cannabis flower in their preparation
A combination of different types of products that together constitute no more than 7 grams of cannabis

These limits are significantly lower than in the neighboring states of Massachusetts and New York. The Department of Consumer Protection said the limits will be reviewed and will likely be increased. The current limits are intended to ensure an adequate supply for both adult consumers and medical marijuana patients, who will still be able to purchase up to 140 grams per month.

Seagull said that all cannabis products will be clearly labeled and must be sold in packages that children will not be able to open.

Although there are limits on transactions, government officials said pharmacies will not record every sale. This means that customers could potentially go to one dispensary, buy 7 grams of cannabis, and then go to another dispensary and buy 7 grams again.

Seagull and the Connecticut Department of Consumer Protection have reported that they expect long queues at dispensaries. Several pharmacies encourage and even require online orders to be placed in advance.

Connecticut state officials said 40 more retail stores and dozens of other cannabis-related businesses could open by the end of 2023, but the stores will need time to expand their operations and obtain state permits.

A 2021 state report estimates that legal adult-use cannabis sales could generate about $26 million in tax revenue in fiscal 2024, and by 2026 that total could rise to $73 million.

__

(Featured image by Kampus Production via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.